Coherus Oncology, Inc. (CHRS) › Weighted Average Diluted SharesCoherus Oncology, Inc. (CHRS) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2017-12-31: 53.13M2018-12-31: 65.03M2019-12-31: 73.19M2020-12-31: 83.49M2021-12-31: 75.45M2022-12-31: 77.63M2023-12-31: 94.16M2024-12-31: 114.55M2025-12-31: 117.14M117.14M2017-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31117.14M+2.3%2026-03-09From 2025-01-012024-12-31114.55M+21.7%2026-03-09From 2024-01-012023-12-3194.16M+21.3%2025-03-17From 2023-01-012022-12-3177.63M+2.9%2025-03-17From 2022-01-012021-12-3175.45M-9.6%2024-03-15From 2021-01-012020-12-3183.49M+14.1%2023-03-06From 2020-01-012019-12-3173.19M+12.5%2022-02-23From 2019-01-012018-12-3165.03M+22.4%2021-02-25From 2018-01-012017-12-3153.13M—2020-02-27From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)